SureTrader Stock Hero Advertisement
Home > Boards > Canadian > Biotechs > Nuvo Research Inc. (TSX:NRI)

We got screwed! I wanted to get in

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
rzdzr Member Profile
 
Followed By 0
Posts 3
Boards Moderated 0
Alias Born 07/15/09
160x600 placeholder
Nuvo Research® Provides Business Update "PR Newswire (Canada)" - 3/5/2015 7:30:00 AM
Nuvo Research® Provides Business Update "PR Newswire (US)" - 3/5/2015 7:30:00 AM
Nuvo Research® Announces 2014 Fourth Quarter & Year-End Results "PR Newswire (Canada)" - 2/19/2015 5:00:00 PM
Nuvo Research® Announces 2014 Fourth Quarter & Year-End Results "PR Newswire (US)" - 2/19/2015 5:00:00 PM
Nuvo Research® Reports Topline Results of Phase 2 Study of WF10™ for the Treatment of Allergic Rhinitis "PR Newswire (Canada)" - 1/30/2015 7:00:00 AM
Nuvo Research® Reports Topline Results of Phase 2 Study of WF10™ for the Treatment of Allergic Rhinitis "PR Newswire (US)" - 1/30/2015 7:00:00 AM
Nuvo Research® Granted Additional U.S. Patent for Treatment of Allergic Rhinitis with WF10™ "PR Newswire (Canada)" - 12/22/2014 7:30:00 AM
Nuvo Research® Granted Additional U.S. Patent for Treatment of Allergic Rhinitis with WF10™ "PR Newswire (US)" - 12/22/2014 7:30:00 AM
Nuvo Research® reports that all patients have completed Phase 2 study of WF10™ for the treatment of allergic rhinitis "PR Newswire (Canada)" - 12/18/2014 7:30:00 AM
Nuvo Research® reports that all patients have completed Phase 2 study of WF10™ for the treatment of allergic rhinitis "PR Newswire (US)" - 12/18/2014 7:30:00 AM
Nuvo Research® reacquires Pennsaid® 2% rights to South America, Central America, South Africa and Israel "PR Newswire (Canada)" - 11/13/2014 7:30:00 AM
Nuvo Research® reacquires Pennsaid® 2% rights to South America, Central America, South Africa and Israel "PR Newswire (US)" - 11/13/2014 7:30:00 AM
Nuvo Research® Announces 2014 Third Quarter Results "PR Newswire (Canada)" - 11/10/2014 5:00:00 PM
Nuvo Research® Announces 2014 Third Quarter Results "PR Newswire (US)" - 11/10/2014 5:00:00 PM
Nuvo Research® plans Phase 3 study of Pennsaid® 2% to support international regulatory approvals "PR Newswire (Canada)" - 11/3/2014 12:01:00 AM
Nuvo Research® Plans Phase 3 study of Pennsaid® 2% to Support International Regulatory Approvals "PR Newswire (US)" - 11/3/2014 12:01:00 AM
Nuvo Research® plans Phase 3 study of Pennsaid® 2% to support international regulatory approvals "PR Newswire (US)" - 11/3/2014 12:01:00 AM
Nuvo Research® Completes WF10™ U.S. Market Study for Treatment of Refractory Allergies "PR Newswire (Canada)" - 10/22/2014 7:30:00 AM
Nuvo Research® Completes WF10™ U.S. Market Study for Treatment of Refractory Allergies "PR Newswire (US)" - 10/22/2014 7:30:00 AM
Nuvo Research® Sells PENNSAID® 2% U.S. Rights for US$45 Million to Horizon Pharma "PR Newswire (Canada)" - 10/17/2014 7:00:00 AM
Nuvo Research® Sells PENNSAID® 2% U.S. Rights for US$45 Million to Horizon Pharma "PR Newswire (US)" - 10/17/2014 7:00:00 AM
Nuvo Research® settles litigation with Mallinckrodt Pharmaceuticals "PR Newswire (Canada)" - 9/8/2014 7:30:00 AM
Nuvo Research® settles litigation with Mallinckrodt Pharmaceuticals "PR Newswire (US)" - 9/8/2014 7:30:00 AM
Nuvo Research® to Present at Rodman & Renshaw 16th Annual Global Investment Conference "PR Newswire (Canada)" - 9/4/2014 7:30:00 AM
Nuvo Research® to Present at Rodman & Renshaw 16th Annual Global Investment Conference "PR Newswire (US)" - 9/4/2014 7:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist